Aktis Oncology, Inc. — Investor Relations & Filings
Aktis Oncology, Inc. is a clinical-stage biotechnology company focused on developing a new class of targeted alpha radiopharmaceuticals to treat cancer. The company aims to expand the breakthrough potential of these therapies to large patient populations, addressing prevalent tumor types historically beyond the reach of conventional radiopharmaceuticals. Aktis utilizes a proprietary miniprotein radioconjugate platform designed to generate tumor-targeting agents with ideal properties for alpha radiotherapy, seeking to safely confer breakthrough efficacy. Its pipeline focuses on precision therapies, with a lead candidate, AKY-1189, currently in a Phase 1b clinical trial for locally advanced or metastatic urothelial carcinoma (mUC).
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Major Shareholding Notification 2026 | 2026-05-14 | English | |
| 10-Q | 2026-05-11 | English | |
| 8-K | 2026-05-11 | English | |
| 8-K | 2026-04-16 | English | |
| 8-K | 2026-03-31 | English | |
| 10-K | 2026-03-30 | English |
Browse filings by year
3 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46723676 | Major Shareholding Notification 2026 | 2026-05-14 | English | ||
| 46723675 | 10-Q | 2026-05-11 | English | ||
| 46723671 | 8-K | 2026-05-11 | English | ||
| 46723679 | 8-K | 2026-04-16 | English | ||
| 46723682 | 8-K | 2026-03-31 | English | ||
| 46723685 | 10-K | 2026-03-30 | English | ||
| 46723686 | Major Shareholding Notification 2026 | 2026-01-20 | English | ||
| 46723687 | Major Shareholding Notification 2026 | 2026-01-20 | English | ||
| 46723689 | Major Shareholding Notification 2026 | 2026-01-14 | English | ||
| 46723691 | S-8 | 2026-01-12 | English | ||
| 46723693 | 8-K | 2026-01-12 | English | ||
| 46723695 | 424B4 | 2026-01-09 | English | ||
| 46723696 | Regulatory Filings 2026 | 2026-01-09 | English | ||
| 46723697 | Regulatory Filings 2026 | 2026-01-08 | English | ||
| 46723698 | 8-A12B | 2026-01-07 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
89bio, Inc.
Clinical-stage biopharma developing therapies for liver and…
|
ETNB | US | Manufacturing |
|
Aardvark Therapeutics, Inc.
Clinical-stage biopharma developing therapeutics for hunger…
|
AARD | US | Manufacturing |
|
Aarey Drugs & Pharmaceuticals Ltd
Manufactures APIs and chemical intermediates for global pha…
|
AAREYDRUGS | IN | Manufacturing |
|
Aarti Drugs Limited
Produces APIs, pharma intermediates, and specialty chemical…
|
AARTIDRUGS | IN | Manufacturing |
|
Aarti Pharmalabs Limited
Manufacturer of APIs, intermediates, and xanthines with glo…
|
AARTIPHARM | IN | Manufacturing |
|
AAYUSH WELLNESS LIMITED
Develops and markets herbal formulations, supplements, and …
|
539528 | IN | Manufacturing |
|
Ab&B Bio-Tech CO., LTD. JS
Biopharmaceutical company engaged in the R&D and commercial…
|
2627 | HK | Manufacturing |
|
Abbisko Cayman Limited
Clinical-stage biopharma focused on discovering and develop…
|
2256 | KY | Manufacturing |
|
Abbott India Ltd.
Provides pharmaceutical solutions in gastroenterology, card…
|
ABBOTINDIA | IN | Manufacturing |
|
ABBOTT LABORATORIES
Global healthcare company in medical devices, diagnostics, …
|
ABT | US | Manufacturing |
Aktis Oncology, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/72594/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=72594 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=72594 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=72594 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 72594}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Aktis Oncology, Inc. (id: 72594)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.